Got $1,000 to invest? These quality ASX shares could be the ones to buy

I think ResMed Inc. (ASX:RMD) and this ASX share would be great options for a $1,000 investment this week. Here's why I like them…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you have $1,000 in a savings account and no immediate plans for it, I would suggest you consider investing it into the share market.

After all, the potential returns on offer from the share market are vastly superior to the paltry interest rates being offered by the big four banks.

Two top ASX shares that I think could generate very strong returns for investors over the next decade are listed below.

Here's why I would invest $1,000 into these shares for 10 years:

BetaShares NASDAQ 100 ETF (ASX: NDQ)

The first option to consider investing $1,000 into is the BetaShares NASDAQ 100 ETF. As its name implies, this popular exchange traded fund provides investors with exposure to the NASDAQ 100. This index comprises the 100 largest non-financial shares on the NASDAQ.

You'll no doubt be familiar with the majority of the companies on this index as they are largely household names. This includes coffee giant Starbucks, tech behemoths Amazon, Apple, Facebook, and Google, electric car company Tesla, and retailer Costco.

As a whole, I think these 100 companies have the potential to grow at a quicker rate than the rest of the global economy over the next decade. In light of this, I expect the BetaShares NASDAQ 100 ETF to provide investors with strong returns for many years to come.

ResMed Inc. (ASX: RMD)

Another option to consider investing $1,000 into is ResMed. I think it is one of the best long term options on the Australian share market and well-positioned for growth over the next decade.

This is because the sleep treatment focused medical device company looks well-placed to profit from the proliferation of obstructive sleep apnoea (OSA). Management estimates that just 20% of OSA sufferers have been diagnosed at this point. This means that there is still a significant market opportunity for the company to capture in the future.

I expect this to underpin above-average earnings growth and drive market-beating returns for investors for the foreseeable future.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended BETANASDAQ ETF UNITS. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ ASX Shares

a woman wearing a close-sitting hat featuring wires and thick computer screen glasses clutches her computer monitor and looks shocked and disturbed as she reads old-fashioned computer text from the screen.
Technology Shares

Here's why ASX 200 tech shares (ASX:XTX) outperformed today

ASX tech shares have taken a turn for the better today.

Read more »

Worker in hard hat looks puzzled with one hand on chin
Resources Shares

Why did the Rio Tinto share price (ASX:RIO) have such a lousy 2021?

We look at what happened to this ASX 200 mining giant's shares last year

Read more »

a miner wearing a hard hat smiles as he stands in front of heavy earth moving equipment on a barren mine site.
Share Gainers

Here's why the Rumble Resources (ASX:RTR) share price is climbing 5%

The mineral explorer's share price is on the rise amid promising drill results.

Read more »

share price high, all time record, record share price, highest, price rise, increase, up,
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Wednesday

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

comical investor reading documents and surrounded by calculators
⏸️ ASX Shares

The ASX reporting wrap-up: WiseTech, Bravura, Seven Group

Just what the investor ordered. Here’s a recap of the companies that reported on Wednesday...

Read more »

Doctor performing an ultrasound on pregnant woman
⏸️ ASX Shares

The ASX reporting wrap-up: Ansell, Kogan, Nanosonics

Just what the investor ordered. Here’s a recap of the companies that reported on Tuesday...

Read more »

blue arrows representing a rising share price ASX 200
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Tuesday

Here are your top 10 biggest gainers in the ASX 200 on Tuesday.

Read more »

unhappy investor considering computer screen
Share Market News

The ASX reporting wrap-up: Charter Hall, Ampol, NIB Holdings

Just what the investor ordered. Here’s a recap of the companies that reported on Monday...

Read more »